Patents by Inventor Yuri Karl Peterson

Yuri Karl Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5HT1F receptor agonists and mitochondrial biogenesis
    Patent number: 11939301
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: March 26, 2024
    Assignees: MUSC Foundation for Research Development, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Christopher C. Lindsey, Craig C. Beeson, Yuri Karl Peterson, Rick G. Schnellmann
  • 5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS
    Publication number: 20210238147
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 5, 2021
    Inventors: Christopher C. LINDSEY, Craig C. BEESON, Yuri Karl PETERSON, Rick G. SCHNELLMANN
  • 5HT1F receptor agonists and mitochondrial biogenesis
    Patent number: 11014892
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: May 25, 2021
    Assignees: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT, The United States Government as Represented by the DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Christopher C. Lindsey, Craig C. Beeson, Yuri Karl Peterson, Rick G. Schnellmann
  • 5HT1F RECEPTOR AGONISTS AND MITOCHONDRIAL BIOGENESIS
    Publication number: 20200055827
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.
    Type: Application
    Filed: November 2, 2017
    Publication date: February 20, 2020
    Inventors: Christopher C. LINDSEY, Craig C. BEESON, Yuri Karl PETERSON, Rick G. SCHNELLMANN
  • Oxindole compounds and pharmaceutical compositions thereof
    Patent number: 10370328
    Abstract: Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: August 6, 2019
    Assignee: MUSC Foundation for Research Development
    Inventors: Craig C. Beeson, Christopher C. Lindsey, Baerbel Rohrer, Yuri Karl Peterson